A FoxL1-CreERT-2A-tdTomato Mouse Labels Subepithelial Telocytes.

The identity of the intestinal stem niche has long remained elusive. Early evidence suggested that Paneth cells, a secretory cell type of the intestinal epithelium, functioned as a key component of the intestinal stem cell niche. Situated in the crypt base, Paneth cells intercalate between intestinal stem cells and express multiple signaling molecules that could promote stem cell activity. However, subsequent studies have shown that Paneth cells are dispensable for intestinal stem cell maintenance, proliferation, and function,, thereby raising doubt over the cellular identity of the intestinal stem cell niche. In recent years, our laboratory, along with others, has shown the important role played by mesenchymal cell populations in maintaining intestinal stem cell function.4, 5, 6, 7, 8 In particular, we identified FoxL1-expressing (FoxL1+) subepithelial telocytes as a critical component of the intestinal stem cell niche and the essential source of Wnt signaling, without which intestinal stem cells cannot survive.,,

To study FoxL1+ telocytes and understand their contribution to gastrointestinal health, we must rely on effective mouse models that enable genetic tracing and cell type–specific gene ablation. Our laboratory previously generated a transgenic FoxL1 mouse line that uses the Cre-loxP system to induce reporter expression and conditional gene ablation specifically within FoxL1+ telocytes. However, this mouse model relied on random integration into the mouse genome and therefore is subject to transgene silencing. In addition, this FoxL1 mouse line does not provide permanent fluorescent labeling of FoxL1+ telocytes; fluorescent labeling of FoxL1+ telocytes therefore can be accomplished only by crossing this mouse to a loxP-dependent reporter line and treating the animals with tamoxifen to activate the reporter allele.

To overcome these limitations, we generated a novel FoxL1-CreERT2-2A-tdTomato (FoxL1) mouse line in which the endogenous FoxL1 promoter drives expression of both a tdTomato fluorescent reporter and the tamoxifen-dependent Cre (Causes recombination) recombinase. An ATG-less CreERT2-2A-tdTomato cassette harboring a neomycin-resistance gene was targeted into the FoxL1 locus directly after the endogenous translational start site of this single-exon gene (Figure 1A and B). Targeting was performed in mouse V6.5 embryonic stem cells, and a properly targeted clone was injected into blastocysts to establish the FoxL1 mouse strain. Subsequent genotyping of the strain was performed with a 3-primer polymerase chain reaction enabling simultaneous detection of both the targeted and wild-type alleles (Figure 1C). This strategy retains all endogenous FoxL1 promoter and 5’ untranslated regions and thus should provide high concordance with endogenous FoxL1 expression.

Figure 1

Targeting a CreER-2A-tdTomato reporter to the endogenous FoxL1 locus. (A) Targeting vector for inserting a CreER-2A-tdTomato cassette at the translational start site of the endogenous FoxL1 locus. Primer locations for validating insertion at the 5’ and 3’ insertion sites are indicated, as are primers used for genotyping of FoxL1 mice (A, B, and C). (B) Polymerase chain reaction assays spanning the 5’ and 3’ arms of homology validate proper gene targeting. (C) Genotyping assay for the FoxL1 mouse strain using a 3-primer (A, B, and C) polymerase chain reaction enables resolution of wild-type (WT) and targeted (Mut) FoxL1 alleles. (D) Endogenous tdTomato expression in the subepithelial telocyte plexus in the jejunum of FoxL1 mice. (E) Sun1GFP expression in a FoxL1Rosa26 mouse after 5 doses of tamoxifen . (F) Overlap of endogenous tdTomato and Sun1GFP expression. PGK, phosphoglycerate kinase I.

To validate Cre activity, FoxL1 mice were crossed to the Rosa26 reporter mouse line, in which the nuclear membrane protein, SUN1, is labeled with 2 tandem copies of superfolder (sf) green fluorescent protein (GFP). The Sun1-sfGFP-myc cassette is expressed from the ubiquitously active Rosa26 locus and is preceded by a CAG promoter and a loxP-3x polyA-loxP cassette, which blocks downstream transcription. Cre-expressing cells remove this transcriptional stop cassette to allow expression of Sun1-sfGFP-myc. Whole-mount direct fluorescence imaging of FoxL1Rosa26 mice showed endogenous tdTomato expression driven by the FoxL1 promoter, which localized to the subepithelial plexus of the jejunum and overlapped extensively with Sun1GFP reporter expression (Figure 1D–F).

Using FoxL1Rosa26 mice, we next assessed recombination efficiency in tissues collected along the proximal-to-distal axis of the gastrointestinal tract. To induce Cre activity, adult FoxL1Rosa26 mice were treated once daily with tamoxifen for 5 consecutive days; tissues were analyzed 6 days after the final tamoxifen dose (Figure 2A). Segments of the stomach, duodenum, jejunum, ileum, and colon were surveyed for FoxL1 and Sun1GFP protein expression by immunohistochemistry (Figure 2B). Recombination efficiency was calculated as the number of FoxL1+Sun1GFP+ nuclei normalized to the total number of FoxL1+ cells. Recombination efficiency varied along the gastrointestinal tract, increasing slightly from the duodenum (64.1%) to the ileum (79.0%), with a decrease in efficiency in the colon (65.7%) (Figure 2C). The highest recombination efficiency was observed in the ileum, while the lowest was observed in the colon. Recombination efficiency in the stomach was 69.0%. In other studies using 3 consecutive days of tamoxifen treatment, we observed similar recombination frequencies ranging from 66.5% to 73.7%, depending on tissue (data not shown).

Figure 2

The FoxL1 promoter drives Cre recombinase and reporter expression in tissues of the gastrointestinal tract. (A) Timeline of tamoxifen injection and tissue-harvesting scheme. (B) Immunohistochemistry of gastrointestinal regions from FoxL1Rosa26 mice (n = 3). Cre activity induces Sun1GFP expression in the nuclear envelopes of subepithelial mesenchymal cells. Boxed regions are shown at higher magnification (right). Co-localization of FoxL1 protein and Sun1GFP is observed (arrows). Scale bars: 50 μm. (C) Recombination efficiency was quantified as the percentage of Sun1GFP+FoxL1+ cells normalized by the total number of FoxL1+ cells. Recombination efficiency increased slightly along the proximal-to-distal axis of the small intestine, with the lowest recombination efficiency observed in the duodenum and the highest observed in the ileum. Error bars represent means with SEM (n = 3). TM, tamoxifen.

To determine the extent of extraintestinal Cre expression, the kidney, liver, pancreas, and lung of FoxL1Rosa26 mice were surveyed for Sun1GFP reporter expression (Supplementary Figure 1). Neither FoxL1 nor Sun1GFP expression was observed in the nuclei of any of these tissues. Furthermore, significant (>2%) Sun1GFP reporter expression was not observed in tissues collected from FoxL1Rosa26 mice that were not induced with tamoxifen (Supplementary Figure 2).

Supplementary Figure 1

FoxL1 recombination was not observed in extraintestinal tissues. FoxL1Rosa26 mice were induced with 3 consecutive days of tamoxifen, and tissues were collected 6 days after the final tamoxifen dose (n = 1). Tissues from the (A–D) kidney, (E–H) liver, (I–L) pancreas, and (M–P) lung were stained for FoxL1 and Sun1GFP. (B, F, J, and N) Overlay of FoxL1 and Sun1GFP channels is shown. (C, G, K, and O) Nuclear staining of FoxL1 was not observed in these extraintestinal tissues. (D, H, L, and P) Accordingly, Sun1GFP reporter expression was not observed. Scale bars: 100 μm.

Supplementary Figure 2

Sun1GFP expression was not observed in FoxL1Rosa26 mice that were not induced with tamoxifen. Gastrointestinal tissues were collected from FoxL1Rosa26 mice that were not treated with tamoxifen. Segments of the (A–D) stomach, (E–H) duodenum, (I–L) jejunum, (M–P) ileum, and (Q–T) colon were stained for FoxL1 and Sun1GFP. (B, F, J, N, and R) Overlay of FoxL1 and Sun1GFP channels is shown. (C, G, K, O, and S) FoxL1 protein is shown in the nuclei of subepithelial mesenchymal cells. (D, H, L, P, and T) Significant Sun1GFP expression was not observed, showing the efficacy of reporter activity. Scale bars: 100 μm.

In sum, we report the derivation and characterization of a novel FoxL1 mouse line that drives tdTomato and Cre expression directly from the FoxL1 locus. Because of the inclusion of a constitutively expressed marker, this model can be used to isolate and study telocytes without prior treatment with tamoxifen, which can have deleterious effects in the mouse stomach. When crossed with a Rosa26 reporter mouse line, we observed Cre activity and subsequent fluorescent reporter expression in the subepithelial mesenchymal cells of gastrointestinal tissues. In using these mice, it should be noted that the FoxL1Rosa26 allele is a Foxl1 null allele. Mice heterozygous for FoxL1, previously known as Fkh6, are phenotypically normal; however, mice null for FoxL1 show developmental delays in gut formation and abnormal proliferation and architecture of the gastrointestinal epithelium. Thus, FoxL1Rosa26 mice should not be homozygosed unless analysis of the FoxL1 null phenotype is intended. This novel mouse model will be made available via the Mutant Mouse Resource and Research Centers (mmrrc.org) and hopefully will become a valuable tool for the investigation of FoxL1+ telocytes and their contribution to the maintenance and functioning of the intestinal stem cell niche.

All authors had access to the study data and approved the final manuscript.